Company Filing History:
Years Active: 2017-2019
Title: Takuhiro Matsumura: Innovator in Mucosal Vaccine Adjuvants
Introduction
Takuhiro Matsumura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of immunology, particularly in the development of adjuvants for mucosal vaccines. With a total of 2 patents, his work focuses on enhancing immune responses through innovative approaches.
Latest Patents
Matsumura's latest patents include an adjuvant for mucosal vaccines designed to provide high safety while inducing sufficient immune responses in mucosal membranes. The first patent describes a protein complex composed of hemagglutinin (HA) subcomponents HA1 and HA2, along with a mutant subcomponent HA3 of botulinum toxin. The second patent reiterates the objective of providing a safe adjuvant that effectively stimulates immune responses on mucosal surfaces, utilizing a similar protein complex.
Career Highlights
Matsumura is affiliated with Osaka University, where he conducts his research and development activities. His work has garnered attention for its potential applications in vaccine development, particularly in enhancing the efficacy of mucosal vaccines.
Collaborations
Some of his notable coworkers include Yukako Fujinaga and Masahiro Yutani, who contribute to the collaborative efforts in advancing research in this field.
Conclusion
Takuhiro Matsumura's innovative work in the development of mucosal vaccine adjuvants highlights his commitment to improving immunological responses. His contributions are poised to make a significant impact on vaccine efficacy and public health.